Loading candles…
Jeena Sikho Lifecare Limited is an Indian healthcare provider specializing in Ayurvedic and alternative medicine. The company offers inpatient (IPD) and outpatient consultations (OPD) alongside Ayurvedic product sales through its network of wellness centers and hospitals. Its services include hospital-based treatments such as Ayurveda, Panchakarma, Naturopathy, and Homeopathy. Operating under the flagship brand Shuddhi Ayurveda, Jeena Sikho Lifecare follows a capital-light business model with both company-owned and franchisee-run clinics. The company has been providing healthcare services in India for the past ten years and has undergone significant infrastructure expansion as of the end of fiscal year 2025. Its business segments cover healthcare, Ayurvedic healthcare, and alternative medicine.
This page is a live market overview for JEENA SIKHO LIFECARE LTD (JSLL) on the NSE. As a listed security, JEENA SIKHO LIFECARE LTD is tracked in the Consumer Services segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for JSLL before placing trades on tick2trade.
As of the latest feed, JSLL last traded at ₹598.1 on NSE, down ₹6.15 (1.02%) from the previous close of ₹604.25. Today's session range is ₹591.3 – ₹612.35, against a 52-week band of ₹492 – ₹849.5. Traded volume today stands at 5.31L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for JSLL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether JSLL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for JEENA SIKHO LIFECARE LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in JSLL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated JSLL option chain page linked from this overview.
| Unaudited Results - Q1-FY26 | To consider and approve the Unaudited financial results for the quarter ended June 30, 2026 | 7 Aug 2026 |
| Audited Results - Q4 & FY26 | To consider and approve the Audited Financial Results (Standalone & Consolidated) for the quarter and year ended 31st March, 2026 and recommend dividend, if … | 30 May 2026 |
| Unaudited Results - Q3-FY25 | To consider and approve the Unaudited Quarterly Financial Results (Standalone & Consolidated) for the period ended December 31, 2025 | 7 Feb 2026 |
| Unaudited Results - Q2-FY25 | To consider and approve the Un-Audited Financial Results (Standalone and Consolidated) along with the Limited Review Report for the quarter ended September 3… | 6 Nov 2025 |
| Fund Raising | 1. To consider and approve the proposal for Employee Stock Option Scheme 2025 in terms of SEBI (Share Based Employee Benefits and Sweat Equity) regulations, … | 27 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 14 Aug 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.